Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Rare Thyroid Therapeutics International AB
AB
Active
Org 5569195109
Klara Norra Kyrkogata 26, 111 22
Stockholm
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2013
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Rare Thyroid Therapeutics International AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
17M
33M
50M
67M
5M
2020
16M
2021
22M
2022
58M
2023
46M
2024
EBITDA
SEK millions
0M
-9M
-17M
-26M
-35M
-30M
2020
-43M
2021
-133M
2022
-244M
2023
-231M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
4 883
15 652
21 910
57 569
46 069
Staff expenses
—
—
—
—
—
EBITDA
−30 210
−43 419
−132 740
−244 340
−231 224
Depreciation & amort.
−1 099
−1 100
−1 099
−1 099
−1 082
EBIT
−31 309
−44 519
−133 839
−245 439
−232 306
Net financials
4
24
746
81
1 290
Profit before tax
−31 306
23 505
1 907
−358
−36 017
Tax
−0
−0
−0
−0
−0
Net profit
−31 306
23 505
1 907
−358
−36 017
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
34 703
56 351
59 626
109 939
134 547
Equity
12 193
35 698
37 605
37 248
1 231
Long-term debt
7 500
0
0
0
0
Short-term debt
15 010
20 653
22 021
72 691
133 316
Total debt
22 510
20 653
22 021
72 691
133 316
Financial ratios
5-year trend
EBITDA margin
-501.9%
This company
15.8%
Market median
-3277% vs market
2020
2024
Equity ratio
0.9%
This company
38.2%
Market median
-98% vs market
2020
2024
Return on equity
-2925.8%
This company
18.4%
Market median
-16001% vs market
2020
2024
Net profit margin
-78.2%
This company
8.1%
Market median
-1065% vs market
2020
2024
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
2020
2024
Debt / equity
108.30×
This company
0.62×
Market median
-17368% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Rare Thyroid Therapeutics International AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
